Jointly provided by the National Hemophilia Foundation, Impact Education, LLC and Postgraduate Institute for Medicine.         This activity is supported by independent educational grants from Novo Nordisk, Inc., CSL Behring, and Shire. Thursday, April 26, 2018 6:00 AM - 7:45 AM Boston Convention and Exhibition Center Room 151AB Boston, MA Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2018 is required. Held in conjunction with AMCP Managed Care & Specialty Pharmacy Annual Meeting 2018. Click here to download the slides from this symposium.   Hot Topics Expert insights on recently approved and emerging hemophilia treatment options Clinical and economic impact of inhibitor development Hemophilia treatment centers (HTCs) overview and application of the comprehensive care model   Expert Faculty Presenters Mark T. Reding, MD Associate Professor of Medicine Division of Hematology, Oncology, and Transplantation Director, Center for Bleeding and Clotting Disorders University of Minnesota Medical Center Michael Zeglinski, RPh Senior Vice President, Specialty Pharmacy OptumRx®/BriovaRx®   Who Should Attend? This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of the AMCP, and other managed health care professionals attending the AMCP 2018 Managed Care and Specialty Pharmacy Annual Meeting.   Statement of Need/Program Overview Hemophilia is a high cost chronic condition with total annual costs that can average $250,000 or more for severe patients. Optimal outcomes require a collaborative and coordinated patient experience. The collaborative team can include an insurer, Hemophilia Treatment Center (HTC), and specialty pharmacy. Specialty pharmacy services can support patient adherence to treatment and assist physicians, plans, and employers in meeting clinical and/or financial goals. This symposium features a Specialty Pharmacy Expert and a leading Hematologist. The program will provide an advanced clinical update and emphasize the need for well-coordinated treatment management, best practices to integrate hemophilia care with payer policies, and the value of having collaboration among all stakeholders. This program designed to engage the faculty and audience to develop solutions for specialty pharmacy professionals to implement within their own setting to improve outcomes for patients with hemophilia.   Educational Objectives At the conclusion of this activity, participants should be able to demonstrate improved ability to: Describe recent insights into the safety, efficacy, and attributes of recently approved and emerging hemophilia treatment options Align recently approved therapies into the current hemophilia treatment algorithm Explain hemophilia-related complications associated with inhibitor development and its significant clinical and economic consequences Apply processes for managed care organizations and specialty pharmacy providers to improve communications and collaborations with hemophilia treatment centers (HTCs)   Agenda Date and Time Thursday, April 26, 2018 6:00 AM - 7:45 AM Boston Convention and Exhibition Center Room 151AB Boston, MA 6:00 AM Pre-Activity Learning Assessment and Opening Comments/Overview 6:05 AM Evolving Clinical Practice Guidelines and Treatment Recommendations Mark T. Reding, MD 6:35 AM Challenges and Opportunities with the Optimal Management of Hemophilia Michael Zeglinski, RPh 7:00 AM Patient Adherence Strategies and Factor Cost Management: Recommendations for Managed Care Pharmacy Michael Zeglinski, RPh 7:25 AM Audience Q&A Session 7:40 AM Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation 7:45 AM Adjournment   Accreditation Information Joint Accreditation Statement In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine, the National Hemophilia Foundation and Impact Education, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Physician Continuing Medical Education The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Continuing Pharmacy Education Postgraduate Institute for Medicine designates this continuing education activity for 1.75 contact hours (0.175 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008162-9999-18-048-L01-P Type of Activity: Application For Pharmacists: Upon receipt of a completed activity evaluation form, you will receive an email from CEcertificate@pimed.com within 3 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service. Please note: Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required. Disclosure of Conflicts of Interest Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity. Americans with Disabilities Act ♿ Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812. Fee Information No additional fee is required to attend this CPE/CME activity. Please note: No additional fee is required to attend this CME/CPE activity; however, registration to the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2018 is required. Pre-registration will close at 12:00 pm on April 25, 2018. Walk-in registration will be available at the time of the program. If you have any questions, please call (215) 619-8812 or email info@impactedu.net.